IDH1 and glioblastoma: For instance, the CGGA cohort includes a higher proportion of recurrent GBM cases and more IDH1-mutant and G-CIMP-positive tumors compared to TCGA, while treatment information (radiotherapy and chemotherapy) is only available in CGGA.